MK-1602oxaliplatincolorectal cancerCRC
…ng to senescence escape. Pharmacological targeting of M7CK with MK-1602 (a novel inhibitor identified by virtual screening, KD = 6.49 μ…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: MK-1602 ×
MK-1602
This drug is selected. Its supporting articles are shown below.